Attomarker

Professor Andrew Shaw recently explained Attomarker's research on Long Covid to BBC correspondent Richard Green. The interview was broadcast on BBC Spotlight on 31 January and also featured insights from Dr David Strain and Vivienne Leonard. (15:43). https://lnkd.in/euPXCGPW

Congratulations Exeter Science Park, Attomarker, Cineon , Diagnexia, Oxi-Tech Solutions Limited on a fascinating look at the Park and the innovation that is transforming lives. 🧬🔬 Watch it again on Iplayer BBC News Spotlight, Evening News: 28/01/2025: https://lnkd.in/eeVgjcya #STEMM #EEDEZ #asseenonTV #EastDevon #sciencepark #BBCnews East Devon District Council Andy Wood Naomi Harnett Tim Child Frances Wadsley Gergana Panteva Tom Winters Zoe Smith Robert Murray Melanie Sealey Dr Sally Basker Jason Buck MCIM Grace Platt Paul Osborne

Brilliant work by Professor Andrew Shaw and the team at Attomarker. I'm incredibly grateful to be part of the trial for this Long Covid test.

Very good news for Attomarker and the South West; bringing forward the early detection of disease using our unique technology. Lucy Turner, Ashley Brewer, Andrew Abbott, Gemma Artz, Michael Bainbridge, Peter Carpenter, James Culy, Steve Conibear, Nathalie D., Dr Matt Halkes, Claire Higdon, Tim Keen, Richard Luxton, Chris May, Colin Piper, James Rowberry, Ralph Singleton

Very proud to be part of a passionate group of academics, partner clinics, leading Long Covid opinion leaders, scientists and patients, all with an ambition to develop a deeper understanding of the underlying biochemistry of an individual and their unique immune responses to the Covid19 Sars 2 virus , that could potentially lead to more personalised therapies decided by our expert partner clinics. This test has also recently been awarded the CAUK regulatory mark.

🩺𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐰𝐢𝐭𝐡 𝐀𝐭𝐭𝐨𝐦𝐚𝐫𝐤𝐞𝐫 Attomarker, based at Exeter Science Park, is revolutionising healthcare with rapid fingertip tests that empower personalised medicine and improve outcomes. 💡𝐊𝐞𝐲 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬: ▪️ 𝐑𝐚𝐩𝐢𝐝 𝐓𝐞𝐬𝐭𝐢𝐧𝐠: Diagnoses bacterial, viral, or co-infections in minutes, reducing hospitalisations and unnecessary antibiotics. ▪️ 𝐋𝐨𝐧𝐠 𝐂𝐨𝐯𝐢𝐝 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: Tailored immunity profiles to guide precise care and booster timing. ▪️ 𝐏𝐨𝐫𝐭𝐚𝐛𝐥𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞𝐬: Point-of-care testing for human and animal health, even in remote areas. ▪️ 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Advanced platforms for unparalled accuracy and predictive health analytics. ▪️ 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐆𝐫𝐨𝐰𝐭𝐡: Partnerships driving groundbreaking diagnostics and patient-centered solutions. Attomarker is paving the way for faster, smarter, and more accessible diagnostics worldwide. 🌍 Read more about the work Attomarker are doing here: https://lnkd.in/eRrvPfyi Dr Sally Basker Matt Roach Jason Buck MCIM Sue McQueenie Anne Mountjoy MCIM Exeter and East Devon Enterprise Zone Andrew Shaw Jonathan Snicker Guy Pengelley Sandy Primrose Yves Le Goff Andrew Vincent Robert Warner Mark Smith Raman Chandrasekar #Attomarker #RapidTesting #HealthcareInnovation #LongCovid #ExeterSciencePark

The Attomarker team was delighted to host Richard Green from the BBC, alongside Sue McQueenie, at the Exeter Science Park. Professor Andrew Shaw spoke to camera about the latest breakthroughs on #LongCovid, #HumanInfection and #LiverHealth. Further updates soon.

Very good news for Attomarker and the South West; bringing forward the early detection of disease using our unique technology. Lucy Turner, Ashley Brewer, Andrew Abbott, Gemma Artz, Michael Bainbridge, Peter Carpenter, James Culy, Steve Conibear, Nathalie D., Dr Matt Halkes, Claire Higdon, Tim Keen, Richard Luxton, Chris May, Colin Piper, James Rowberry, Ralph Singleton

🚨MECFS & Long Covid need to invade more the public domain🚨I’ve the feeling that billions are donated by phylantropers and other NGOs in health fields like cancers, rare genetic disorders, Alzheimer and so on. Although there is something supporting #mecfs & #longcovid, that is nothing comparable?Why? because among the public there is no proper understanding of the global burden of ME/CFS-long covid and how patients suffer.We don’t need only trials and evidence, but entire clinical and research areas dedicated for these diseases.To do so, grants are not enough. We need a huge amount of donations. And to do so, I think we also need to go out of our confort zones and try to engage with different levels of the society.I have something in mind in this regard, maybe will fail, but I’ll try. It’s about art and medicine, hope to reach different levels of support. At least in Italy , I don’t expect to have otherwise any other chances of major funding

🚨 In response to the UK Government's Get Britain Working White Paper, Long Covid Support has written a statement. "The issue of employment, welfare and health cannot be addressed without urgently addressing ongoing Covid-19 infections, public health and Long Covid, as a matter of national policy." 🔗 Read our full statement here: https://lnkd.in/eW57Fg7i Please share widely. #longcovid #longcovidkids #longcovidcommunity #whitepaper #getbritainworking #employment #welfare #health #covidisnotover #publichealth #mitigations #stopcovid #preventlongcovid #ventilation #cleanair #maskup #charity #statement